Medidata Expands Collaboration with CTI Clinical Trial and Consulting, Shaping a New Era of Patient-Centric Studies
Medidata and CTI Clinical Trial and Consulting deepened their 12-year partnership, with CTI achieving accreditation in Medidata eCOA to strengthen patient data collection. The expansion integrates Medidata's Patient Experience solutions with CTI's research services across oncology, metabolic, cardiovascular, CNS, and immune conditions, aiming for what the page calls 'seamless integration for both patients and study teams' through real-time, high-quality digital data collection. The page notes Medidata eCOA was recently named a Leader in Everest Group's PEAK Matrix Assessment.
Medidata is a Dassault Systèmes company supplying the clinical-trial EDC and data platform (Rave) most sponsors and CROs already run live trials on, now with an AI layer built in.
This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
Published by Medidata on its own site — read the original case study on medidata.com ↗
Related use cases
- 01Data management transformation using Medidata's integrated product suite — (no dedicated case-study URL surfaced; featured on customer-testimonials page
- 02Worldwide Clinical Trials and Medidata Announce Strategic Partnership to Embed Medidata AI Across the Full Trial Lifecycle, Bolstering Study Execution and Delivery Excellence
- 03Medidata Expands Partnership with The Menarini Group, Deploying Medidata's Study Build AI Technology to Accelerate Global Oncology Pipeline
- 04Replaced delayed site payments with Medidata Site Payments Managed Services
- 05Streamlined oncology trials on the Medidata platform (video case study
- 06Onconova Uses Rave to Improve Patient Screening